Accurate and rapid diagnostic tests are critical for achieving control of COVID-19, a pandemic illness caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Diagnostic tests for COVID-19 fall into two main categories: molecular and antigen tests. The reverse transcription real-time-quantitative polymerase chain reaction (RT-qPCR) has become the gold standard for diagnosis of the COVID-19; however, this test has many limitations that include potential false-negative results and precarious availability of test materials. The isothermal PCR or Loop-Mediated Isothermal Amplification (LAMP) method has generated substantial interest as an alternative or complement to RT-qPCR, as some might be cheaper and easier to implement at the point of care. To our knowledge, it is the first Algerian study that wanted to compare two different molecular biology methods: RT-qPCR and LAMP for rapid diagnosis of COVID-19. In this review, we wanted to compare the CTs observed by RT-qPCR with those observed by LAMP in the same laboratory.
Introduction: Several genetic association studies have investigated Inflammatory Arthropathy (IA), a term used in this study to refer specifically to rheumatoid arthritis classified according to the 1987 American College of Rheumatology (ACR) criteria and the 2010 ACR/EULAR classification criteria. However, limited data are available regarding the role of the Angiotensin‑Converting Enzyme (ACE) Insertion/Deletion (I/D) polymorphism across different populations. The present study aimed to evaluate the association between the ACE I/D polymorphism and IA susceptibility in the Western Algerian population Materials and Methods: A total of 101 patients diagnosed with IA and 140 healthy unrelated controls were enrolled. Genotyping of the ACE I/D polymorphism (rs4340) was performed using multiplex Polymerase Chain Reaction (PCR). Genotype and allele frequencies were compared between groups, and Odds Ratios (ORs) with 95% Confidence Intervals (CIs) were calculated using SPSS software. Results: Our findings indicated a strong risk of IA associated with genotypic distributions of ACE I/D, DD ((OR) = 4(1,02-15.72), p-value = 0.04, as well as the dominant model (ID+DD) (OR) =16,01(1-29), p-value = 0.01, in the development of IA. However, no significant association was observed between ACE I/D genotypes and age in our study. Discussion: These findings suggest that the ACE I/D polymorphism, particularly the D allele, may contribute to IA susceptibility, possibly through inflammatory pathways involving the renin-angiotensin system. Conclusion: This is the first study in the Algerian population to demonstrate a potential association between the ACE I/D polymorphism and rheumatoid arthritis.